EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (6 days ago)
Edelweiss Connect at front of the move to non-animal testing with SaferSkin™ https://t.co/CLqvbKP6Xj #AnimalTesting… https://t.co/K2uQcj6qw7
Edelweiss Connect (2 weeks ago)
@UniLeiden Bob van de Water leads EU-ToxRisk. Aiming for paradigm shift in toxicological testing: reliable, animal-… https://t.co/DNekLz31pX
Edelweiss Connect (2 weeks ago)
#eutoxrisk Bob van de Water: "10 case studies, different partners in different disciplines, all generating data! Ed… https://t.co/FxP9IQwWSQ
Edelweiss Connect (2 weeks ago)
Prof Bob van de Water, coordinator of EU-ToxRisk, largest EU programme in toxicology. 39 partner organisations acro… https://t.co/3obHsS2mCv
Edelweiss Connect (2 weeks ago)
@UniLeiden spin-off develops 50+ cell lines “reporting” stress response signaling toxicity. Genetically-engineered… https://t.co/xSa4JZsGOA

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@edelweissconnect.com